<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0213264</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1117</journal-id>
<journal-id journal-id-type="nlm-ta">Biol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Biol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Biological psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-3223</issn>
<issn pub-type="epub">1873-2402</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27837921</article-id>
<article-id pub-id-type="pmc">5285483</article-id>
<article-id pub-id-type="doi">10.1016/j.biopsych.2016.08.035</article-id>
<article-id pub-id-type="manuscript">NIHMS817132</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Pleiotropic MET Receptor Network: Circuit Development and the Neural-Medical Interface of Autism</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Eagleson</surname>
<given-names>Kathie L.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xie</surname>
<given-names>Zhihui</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Levitt</surname>
<given-names>Pat</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Program in Developmental Neurogenetics, Institute for the Developing Mind Children’s Hospital Los Angeles</aff>
<aff id="A2"><label>2</label>Department of Pediatrics, Keck School of Medicine of University of Southern California, Los Angeles, CA 90027</aff>
<author-notes>
<corresp id="FN1">Corresponding author and contact information: Pat Levitt, PhD, The Saban Research Institute, Children’s Hospital Los Angeles, 4650 Sunset Blvd Mail Stop #313, Los Angeles, CA 90027, 323-361-7868, <email>plevitt@med.usc.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>20</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>15</day>
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>3</month>
<year>2018</year>
</pub-date>
<volume>81</volume>
<issue>5</issue>
<fpage>424</fpage>
<lpage>433</lpage>
<!--elocation-id from pubmed: 10.1016/j.biopsych.2016.08.035-->
<abstract>
<p id="P2">People with autism spectrum disorder (ASD) and other neurodevelopmental disorders (NDDs) are behaviorally and medically heterogeneous. The combination of polygenicity and gene pleiotropy - the influence of one gene on distinct phenotypes - raises questions of how specific genes and their protein products interact to contribute to NDDs. A preponderance of evidence supports developmental and pathophysiological roles for the MET receptor tyrosine kinase, a multi-functional receptor that mediates distinct biological responses depending upon cell context. MET influences neuron architecture and synapse maturation in the forebrain, and regulates homeostasis in gastrointestinal and immune systems, both commonly disrupted in NDDs. Peak expression of synapse-enriched MET is conserved across rodent and primate forebrain, yet regional differences in primate neocortex are pronounced, with enrichment in circuits that participate in social information processing. A functional risk allele in the <italic>MET</italic> promoter, enriched in subgroups of children with ASD, reduces transcription and disrupts socially-relevant neural circuits structurally and functionally. In mice, circuit-specific deletion of <italic>Met</italic> causes distinct atypical behaviors. MET activation increases dendritic complexity and nascent synapse number, but synapse maturation requires reductions in MET. MET mediates its specific biological effects through different intracellular signaling pathways, and has a complex protein interactome that is enriched in ASD and other NDD candidates. The interactome is co-regulated in developing human neocortex. We suggest that a gene as pleiotropic and highly regulated as <italic>MET</italic>, together with its interactome, is biologically relevant in normal and pathophysiological contexts, impacting central and peripheral phenotypes that contribute to NDD risk and clinical symptoms.</p>
</abstract>
<kwd-group>
<kwd>forebrain</kwd>
<kwd>synapse development</kwd>
<kwd>protein interactome</kwd>
<kwd>symptom heterogeneity</kwd>
<kwd>immune system</kwd>
<kwd>gastrointestinal system</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>